Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02829918
Title Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

gallbladder carcinoma

biliary tract benign neoplasm

Therapies

Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.